EP2872145
SAMBRÆDD BENSASEPÍN Í MEÐFERÐ VIÐ TOURETTE-HEILKENNI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
12.7.2013EP published:
9.3.2022EP application number:
13815988.4
EP translation filed:
1.6.2022Grant published:
15.7.2022EPO information:
European Patent Register
Max expiry date:
11.7.2033Expiry date:
11.7.2026Next due date:
31.7.2026
Title in English:
FUSED BENZAZEPINES FOR TREATMENT OF TOURETTE'S SYNDROMELanguage of the patent:
English
Timeline
Today
12.7.2013EP application
9.3.2022EP Publication
1.6.2022Translation submitted
15.7.2022Registration published
11.7.2026Expires
Owner
Name:
Emalex Biosciences, Inc.Address:
20451 Seneca Meadows Parkway, Germantown, MD 20876, US
Inventor
Name:
CHIPKIN, Richard, E.Address:
Bethesda, MD 20814, US
Name:
KWAN, RudolfAddress:
Summit, NJ 07901, US
Agent
Name:
Budde Schou A/SAddress:
Dronningens Tværgade 30, DK
Priority
Number:
201261671044 PDate:
12.7.2012Country:
US
Classification
Categories:
A61K 31/55, A61P 25/14
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 29.6.2022
Expires: 11.7.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 28.6.2023
Expires: 11.7.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 6.6.2024
Expires: 11.7.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 7.7.2025
Expires: 11.7.2026
Payer: Árnason Faktor ehf.